Larry Mathis Financial Planning, LLC

Position in ABBV — AbbVie Inc.

CIK 2118274 PHOENIX, AZ

Position in ABBV

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,433,089

New position

Shares Held

5,695

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

1.97%

of 13F equity value

Holder Rank

#2,221

of 4,153 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Larry Mathis Financial Planning, LLC holds $4,999,669 across 6 Drug Manufacturers - General names. ABBV ranks #1 (28.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	5,695	$1,433,089
2	MRK	Merck & Co., Inc.	9,013	$1,158,170
3	NVS	Novartis AG	5,510	$863,527
4	GILD	Gilead Sciences, Inc.	5,134	$648,629
5	BMY	Bristol Myers Squibb Co	8,897	$512,645
6	GSK	GSK plc	7,318	$383,609

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,433,089	5,695	—	Shares	Sole	2026-07-27
No filing history on record for this holder in this stock.